Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 3040-3045, August 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mishkin, S. Y.
Right arrow Articles by Mishkin, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mishkin, S. Y.
Right arrow Articles by Mishkin, S.

Inhibition of Local and Metastatic Hepatoma Growth and Prolongation of Survival after Induction of Hypothyroidism1

S. Y. Mishkin2, R. Pollack, M. A. Yalovsky, H. P. Morris and S. Mishkin

Department of Medicine, Royal Victoria Hospital and McGill University Clinic, Montreal, Quebec H3A 1A1, Canada, [S. Y. M., R. P., M. A. Y., S. M.] and Department of Biochemistry, Howard University School of Medicine, Washington, D. C. 20059 [H. P. M.]

The local growth rate of Morris Hepatoma 44 (generation time, 6 months) was inhibited by 66 to 87%, and host survival was prolonged by 36 to 78% after the induction of hypothyroidism within 2 weeks of tumor implantation by propylthiouracil (0.1% in Purina chow), 131I (1 mCi/100 g body weight i.p.), or surgical thyroidectomy. In additional experiments, we studied the effects of inducing hypothyroidism (131I) at different stages in the natural history of Morris Hepatoma 44 on local and metastatic growth as well as on host survival. Induction of hypothyroidism within 2 weeks of tumor implantation (Group I) reduced local tumor growth as well as the number and size of pulmonary metastases, and prolonged survival by 70 to 80%. Induction of hypothyroidism at 6 weeks postimplantation when tumors were palpable (Group II) inhibited local growth by 39%, reduced the number and size of pulmonary metastases by approximately 80%, and prolonged host survival by 35%. Initiation of 131I treatment at 11 weeks when microscopic pulmonary emboli were present in most animals (Group III) reduced local growth by 19% and the number and size of pulmonary metastases by 72 and 50%, respectively. In this case, survival was prolonged by 17%. We conclude from these results that the local and metastatic growth of Morris Hepatoma 44 as well as host survival are thyroid hormone-dependent processes. The mechanisms responsible for these observations remain to be explained.

1 This study was supported by grants from the National Cancer Institute of Canada and USPHS Grant CA 10729, and is dedicated to the memory of Moe Yalovsky.

2 Chercheur Boursier of the Quebec Medical Research Council. To whom requests for reprints should be addressed, at the Department of Medicine, Royal Victoria Hospital, 687 Pine Avenue West, Montreal, Quebec, Canada H3A 1A1.

Received 11/10/80. Accepted 4/22/81.




This article has been cited by other articles:


Home page
Arch Otolaryngol Head Neck SurgHome page
M. Nelson, A. Hercbergs, L. Rybicki, and M. Strome
Association between development of hypothyroidism and improved survival in patients with head and neck cancer.
Arch Otolaryngol Head Neck Surg, October 1, 2006; 132(10): 1041 - 1046.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K.-h. Lin, H.-y. Shieh, and H.-C. Hsu
Negative Regulation of the Antimetastatic Gene Nm23-H1 by Thyroid Hormone Receptors
Endocrinology, July 1, 2000; 141(7): 2540 - 2547.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.